The biotechnology sector has entered the second half of 2026 riding a wave of unprecedented financial momentum....
Treatment Innovations
In an urgent move to curb the spread of the Bundibugyo ebolavirus (BDBV) in the Democratic Republic...
The landscape of metabolic healthcare is undergoing a seismic shift. Eli Lilly and Company, currently the world’s...
By BioPharma Dive’s studioID The journey of a drug from a controlled laboratory environment to a patient...
In the high-stakes arena of drug discovery, the timeline from a promising hit to a viable clinical...
The American Diabetes Association (ADA) national conference, usually a clinical sanctuary for the exchange of life-saving medical...
In June 2025, the U.S. Food and Drug Administration (FDA) unveiled the Commissioner’s National Priority Voucher (CNPV)...
In a landmark development for oncology, GSK has announced that its experimental antibody-drug conjugate (ADC), risvutatug rezetecan...
By [Your Name/Journalistic Staff] Published July 9, 2026 In a significant blow to the landscape of neurodegenerative...
By Jacob Bell Published July 9, 2026 In a significant blow to its strategic pivot toward neurodegenerative...
